What Matters Most to Patients and Rheumatologists? A Discrete Choice Experiment in Rheumatoid Arthritis-Reference-Cited by-同舟云学术

What Matters Most to Patients and Rheumatologists? A Discrete Choice Experiment in Rheumatoid Arthritis

Published:2020-02-22 Issue:4 Volume:37 Page:1479-1495
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Díaz-Torné Cesar,Urruticoechea-Arana Ana,Ivorra-Cortés José,Díaz Silvia,Dilla Tatiana,Sacristán José Antonio,Inciarte-Mundo José,Comellas Marta,Prades Miriam,Lizán Luis

Funder

Eli Lilly and Company

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12325-020-01258-5.pdf

Reference50 articles.

1. Smolen JS, Aletaha D. Rheumatoid arthritis. Lancet. 2016;388:2023–38.

2. Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, et al. Rheumatoid arthritis. Nat Rev Dis Prim. 2018;4(18001):1–23.

3. Sanmartí R, García-Rodríguez S, Álvaro-Gracia JM, Andreu JL, Balsa A, Cáliz R, et al. Actualización 2014 del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en la artritis reumatoide. Reumatol Clín. 2015;11(5):279–94.

4. Smolen JS, Landewé R, Bijlsma J, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis. 2017;76(6):960–77.

5. Pasma A, van’t Spijker A, Hazes JMW, Busschbach JJV, Luime JJ. Factors associated with adherence to pharmaceutical treatment for rheumatoid arthritis patients: A systematic review. Semin Arthritis Rheum. 2013;43(1):18–28. https://doi.org/10.1016/j.semarthrit.2012.12.001.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indicative features of tissue and microbial sensitization in the pathogenesis of generalized parodontitis associated with rheumatoid arthritis;Medicni perspektivi;2024-06-28

2. Patients’ Preferences for Systemic Lupus Erythematosus Treatments—A Discrete Choice Experiment;The Patient - Patient-Centered Outcomes Research;2024-01-25

3. What benefit–risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experiment;RMD Open;2024-01

4. Development of an Interactive Tool to Support Shared Decision‐Making in Rheumatoid Arthritis: Treatment Attribute Preference;Arthritis Care & Research;2023-11-13

5. Patient's Perspective of Shared Decision-Making in Rheumatoid Arthritis Treatment: A Grounded Theory Exploration;The Qualitative Report;2023-07-10